🇺🇸 FDA
Patent

US 7172770

Mesoporous compositions for use in drug delivery

granted A61KA61K9/143A61K9/145

Quick answer

US patent 7172770 (Mesoporous compositions for use in drug delivery) held by The Board of Regents of the University of Texas System expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K9/143, A61K9/145, A61P, A61P39/06